Gene · 7706
Papers2,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Fish Rhbdd3 positively regulates IFN response through RIG-I signaling pathway. | Fish Shellfish Immunol | 2023 | 37758095 | PubTator, text mining | PubMed |
| The Arf-GEF GBF1 undergoes multi-domain structural shifts to activate Arf at the Golgi. | Front Cell Dev Biol | 2023 | 37745300 | PubTator, text mining | PubMed |
| LINC00955 suppresses colorectal cancer growth by acting as a molecular scaffold of TRIM25 and Sp1 to Inhibit DNMT3B-mediated methylation of the PHIP promoter. | BMC Cancer | 2023 | 37742010 | PubTator, text mining | PubMed |
| Characterization of tumor microenvironment and tumor immunology based on the double-stranded RNA-binding protein related genes in cervical cancer. | J Transl Med | 2023 | 37735483 | PubTator, text mining | PubMed |
| Human papillomavirus associated cervical lesion: pathogenesis and therapeutic interventions. | MedComm (2020) | 2023 | 37719443 | PubTator, text mining | PubMed |
| Independent loss events of a functional tetherin gene in galliform birds. | J Virol | 2023 | 37712707 | PubTator, text mining | PubMed |
| Protein ISGylation: a posttranslational modification with implications for malignant neoplasms. | Explor Target Antitumor Ther | 2023 | 37711589 | PubTator, text mining | PubMed |
| Genomic Alterations Associated with Estrogen Receptor Pathway Activity in Metastatic Breast Cancer Have a Differential Impact on Downstream ER Signaling. | Cancers (Basel) | 2023 | 37686693 | PubTator, text mining | PubMed |
| Differential Type-I Interferon Response in Buffy Coat Transcriptome of Individuals Infected with SARS-CoV-2 Gamma and Delta Variants. | Int J Mol Sci | 2023 | 37685953 | PubTator, text mining | PubMed |
| Prevalence of Peri-Implant Disease in Patients with Stage III or IV Periodontitis: Results of a Long-Term Follow-Up from a Specialized Periodontal Practice. | J Clin Med | 2023 | 37685613 | PubTator, text mining | PubMed |
| Zika virus targets human trophoblast stem cells and prevents syncytialization in placental trophoblast organoids. | Nat Commun | 2023 | 37684223 | PubTator, text mining | PubMed |
| Association between oral health and cognitive function among Chinese older adults: the Taizhou imaging study. | BMC Oral Health | 2023 | 37670297 | PubTator, text mining | PubMed |
| N6 -methyladenosine-modified circFUT8 competitively interacts with YTHDF2 and miR-186-5p to stabilize FUT8 mRNA to promote malignant progression in lung adenocarcinoma. | Thorac Cancer | 2023 | 37669906 | PubTator, text mining | PubMed |
| Mechanism of multidrug resistance to chemotherapy mediated by P‑glycoprotein (Review). | Int J Oncol | 2023 | 37654171 | PubTator, text mining | PubMed |
| Posttranslational ISGylation of NLRP3 by HERC enzymes facilitates inflammasome activation in models of inflammation. | J Clin Invest | 2023 | 37651190 | PubTator, text mining | PubMed |
| Identification of endoplasmic reticulum stress-related lncRNAs in lung adenocarcinoma by bioinformatics and experimental validation. | Ann Med | 2023 | 37643369 | PubTator, text mining | PubMed |
| Large yellow croaker (Larimichthys crocea) mitofusin 2 inhibits type I IFN responses by degrading MAVS via enhanced K48-linked ubiquitination. | Mar Life Sci Technol | 2023 | 37637256 | PubTator, text mining | PubMed |
| Sex-biased genome-editing effects of CRISPR-Cas9 across cancer cells dependent on p53 status. | iScience | 2023 | 37636042 | PubTator, text mining | PubMed |
| Therapeutic Implications of PTEN in Non-Small Cell Lung Cancer. | Pharmaceutics | 2023 | 37631304 | PubTator, text mining | PubMed |
| TRIM14 Overexpression Induces Chemoresistance and Malignant Behaviors of Hepatocellular Carcinoma Cells by Activating the STAT3/HIF-1α Pathway. | Int J Mol Sci | 2023 | 37628777 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7706/papers?page=19